Status:
COMPLETED
Effect of Meningococcal Conjugate Vaccine on Meningococcal Carriage
Lead Sponsor:
Centers for Disease Control and Prevention
Collaborating Sponsors:
Georgia Department of Human Resources
Maryland Department of Health and Mental Hygiene
Conditions:
Meningitis
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether the new meningococcal conjugate vaccine (MCV4) can reduce asymptomatic carriage of meningococcal bacteria, and thus decrease the transmission of these...
Detailed Description
The purpose of this study is to determine whether the new meningococcal conjugate vaccine (MCV4) can reduce asymptomatic carriage of meningococcal bacteria, and thus decrease the transmission of these...
Eligibility Criteria
Inclusion
- High school students (grades 9-12) enrolled in participating schools
Exclusion
- Contraindications to vaccine administration
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
End Date :
May 1 2007
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT00119080
Start Date
August 1 2006
End Date
May 1 2007
Last Update
March 19 2007
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.